Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Stuff is happening

<< Previous

Bullboard Posts

Next >>

Comment by Angler101on Oct 19, 2023 8:37pm

101 Views

Post# 35692168

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Stuff is happening

Lol....you’re the one that’s been insulting anyone on this forum that doesn’t fall in with your constant whining, and then bragging about how rich and educated you are, and you’re telling ME to settle down?......in all your crying because Matt hasn’t moved things along quite quickly enough to suit your pathetic greed, never once have I ever seen you mention the thousands of poor desperate people who actual need the approval of this drug to save their lives.....all you’re worried about is your precious money.....why don’t you “run along now” and invest in something that will get you a quicker return...

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1